NCT06381362 (IGOMIPS) is a clinical trial of Minimally invasive pancreatic surgery in Pancreatic Surgery, sponsored by Associazione Italiana per lo Studio del Pancreas.

Who is sponsoring NCT06381362?

NCT06381362 is sponsored by Associazione Italiana per lo Studio del Pancreas.

What drugs are being tested in NCT06381362?

Interventions in NCT06381362: Minimally invasive pancreatic surgery.

What condition does NCT06381362 study?

NCT06381362 studies Pancreatic Surgery.

Is NCT06381362 still recruiting?

NCT06381362 is currently recruiting now. Last updated 24 April 2024.

Last reviewed 2024-04-24 · How we verify

NCT06381362: IGOMIPS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Italian Registry of Minimally Invasive Pancreatic Surgery

Recruiting now Last updated 24 April 2024

What this trial tests

trial testing Minimally invasive pancreatic surgery in Pancreatic Surgery in 2,300 participants. Currently enrolling.

Timeline

28 February 2019

Primary endpoint
28 February 2029

28 February 2029

Quick facts

Lead sponsor	Associazione Italiana per lo Studio del Pancreas
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,300
Start date	28 February 2019
Primary completion	28 February 2029
Estimated completion	28 February 2029
Sites	1 location across Italy

Drugs / interventions tested

Minimally invasive pancreatic surgery

Conditions studied

Pancreatic Surgery — all drugs for Pancreatic Surgery →

Sponsor

Associazione Italiana per lo Studio del Pancreas — full company profile →

Who can join

18 and older, any sex, with Pancreatic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assess the prevalence of minimally invasive pancreatic surgery in the country and its outcomes

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pancreatic Surgery

Currently open trials in the same condition.

NCT07248527 — PAN-ICIS Study: ICIS for Early Detection of Infectious Complications in Pancreatic Surgery · active not recruiting
NCT05603702 — STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis · Phase 1 · recruiting

Other Associazione Italiana per lo Studio del Pancreas trials

Trials by the same sponsor.

NCT05724992 — Familial Pancreatic Cancer PROPHilation Program in Italy · NA · recruiting
NCT05733130 — Italian Registry Chronic Pancreatitis · recruiting
NCT04793932 — Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) · Phase 3 · active not recruiting
NCT04095195 — Registry of Subjects at Risk of Pancreatic Cancer · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06381362 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Associazione Italiana per lo Studio del Pancreas
Last refreshed: 24 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06381362.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing